The Benefits of Placenta-Based Biomaterials Over Risky Placenta Pills

Discover why placenta-based biomaterials are a safer and more effective option for wound healing than risky placenta pills, backed by scientific research and clinical applications.
Recent research highlights the advantages of using placental biomaterials instead of ingesting placenta in the form of pills or other products. While some have promoted placenta consumption for purported health and mood benefits, scientific evidence suggests that applying processed placenta as a biomaterial can be a safer and more effective approach for wound healing and tissue regeneration.
The placenta, an organ formed during pregnancy, supplies nutrients and immune support to the developing fetus through the umbilical cord. Historically, some women have consumed placentas post-childbirth, believing it enhances recovery or boosts health. However, these practices often involve raw or minimally processed placentas, which can pose health risks due to pathogens, and may diminish the organ's beneficial components through improper processing.
In contrast, placenta-based biomaterials undergo rigorous laboratory processing, including sterilization, to ensure safety and effectiveness. These materials retain vital nutrients, stem cells, and bioactive molecules that promote healing, reduce inflammation, and minimize scarring. Clinical applications include treatment for chronic wounds such as diabetic foot ulcers, where studies have shown significant improvement in healing rates.
Furthermore, placental stem cells have promising therapeutic uses, including repairing difficult-to-harvest organs like the heart, liver, and nerves. Research involving stem cell transplantation indicates potential in reversing neurodegenerative diseases and tissue degeneration.
The key distinction lies in the processing: ingested placenta products may carry risks from pathogens and may reduce beneficial components, whereas placental biomaterials are carefully prepared and approved for clinical use. The FDA has approved several placenta-derived biomaterials to aid wound healing and tissue regeneration.
Therefore, while eating placenta is unlikely to provide health benefits and can be hazardous, using bioengineered placenta-based biomaterials in medical settings offers a safe and effective option for wound repair and regenerative medicine, leveraging the placenta’s natural healing properties.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Boehringer Ingelheim Receives U.S. Approval for Innovative Lung Cancer Treatment
Boehringer Ingelheim has received FDA approval for zongertinib, a new oral treatment for HER2-mutant non-small cell lung cancer, offering hope for patients with limited options.
Unexpected Births: NZ Ambulance Teams Share Their Experiences During Sudden Out-of-Hospital Deliveries
New Zealand ambulance crews share their experiences managing unexpected out-of-hospital births, highlighting challenges and the importance of specialized emergency training to ensure safe deliveries.
Understanding How Cancer Misinformation Exploits Human Psychology
Cancer misinformation spreads rapidly on social media by exploiting emotions and psychological biases, risking delays in treatment and trust in healthcare. Learn how to recognize and resist false claims to make better health decisions.
Why Flossing is Essential for Children's Dental Health—even with Baby Teeth
Learn why flossing your child's baby teeth is vital for their oral health, development, and preventing future dental issues, with expert tips on establishing effective routines.



